These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37480993)

  • 1. Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses.
    Wang HH; Chen Y; Liu X; Zaorsky NG; Mani K; Niu ZM; Zheng BY; Zeng HY; Yan YY; Li YJ; He Y; Ji CZ; Sun BS; Meng MB
    Radiother Oncol; 2023 Oct; 187():109817. PubMed ID: 37480993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
    Lee J; Kim WC; Yoon WS; Koom WS; Rim CH
    Oral Oncol; 2020 Aug; 107():104757. PubMed ID: 32388412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Soltys SG; Grimm J; Milano MT; Xue J; Sahgal A; Yorke E; Yamada Y; Ding GX; Li XA; Lovelock DM; Jackson A; Ma L; El Naqa I; Gibbs IC; Marks LB; Benedict S
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):112-123. PubMed ID: 33516580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
    Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
    Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiotherapy Reirradiation Is Safe in Patients With Lung Cancer With In-Field Enlarged Tumor Recurrence.
    Berber T; Yıldırım BA; Kandemir Gürsel Ö
    Technol Cancer Res Treat; 2024; 23():15330338231208616. PubMed ID: 38860536
    [No Abstract]   [Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy.
    Peulen H; Karlsson K; Lindberg K; Tullgren O; Baumann P; Lax I; Lewensohn R; Wersäll P
    Radiother Oncol; 2011 Nov; 101(2):260-6. PubMed ID: 22056534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.
    Kinj R; Doyen J; Hannoun-Lévi JM; Naghavi AO; Chand ME; Baudin G; Ferrero JM; François E; Evesque L; Borchiellini D; Benezery K; Bondiau PY
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e15-e21. PubMed ID: 32641243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer.
    Bergamin S; Eade T; Kneebone A; Booth J; Hsiao E; Schembri GP; Szymura K; Le A; Kwong C; Brown C; Hunter J; Hruby G
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1172-1178. PubMed ID: 32659332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes.
    Cozzi S; Finocchi Ghersi S; Bardoscia L; Najafi M; Blandino G; Alì E; Augugliaro M; Vigo F; Ruggieri MP; Cardano R; Giaccherini L; Iori F; Botti A; Trojani V; Ciammella P; Iotti C
    Strahlenther Onkol; 2023 Jun; 199(6):554-564. PubMed ID: 36732443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
    Echevarria MI; Yang GQ; Chen DT; Kirtane K; Russell J; Kish J; Muzaffar J; Otto K; Padhya T; McMullen C; Patel K; Chung CH; Caudell JJ
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):341-347. PubMed ID: 37105404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
    Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
    Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.
    Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK
    Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data.
    Bai H; Wang XF; Xu YH; Zaorsky NG; Wang HH; Niu GM; Li JC; Dong Y; Li JY; Yu L; Chen MF; Lu XT; Yuan ZY; Yang JL; Meng MB
    Radiother Oncol; 2024 Nov; 200():110529. PubMed ID: 39255923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic Reirradiation with Stereotactic Body Radiation Therapy (SBRT) for Recurrent Advanced Non-Small Cell Lung Cancer (NSCLC).
    Ross D; Chan D; Kuo E; Harkenrider M
    Pract Radiat Oncol; 2024; 14(3):234-240. PubMed ID: 38387781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.
    Trovo M; Minatel E; Durofil E; Polesel J; Avanzo M; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Rumeileh IA; Trovo MG
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1114-9. PubMed ID: 24661664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.